March 7 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- ENTERED INTO COLLABORATION WITH AUSTRALIAN AND NEW ZEALAND CHILDREN'S HAEMATOLOGY / ONCOLOGY GROUP
- COLLABORATION FOR PHASE II CLINICAL STUDY EXAMINING PAXALISIB IN CHILDREN WITH ADVANCED SOLID TUMOURS, INCLUDING BRAIN TUMOURS
March 7 (Reuters) - Kazia Therapeutics Ltd (KZA) : ENTERED INTO...
Add to My Watchlist
What is My Watchlist?